Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.55K Hold
410
﹤0.01% 3623
2026
Q1
$6.31K Hold
410
﹤0.01% 3506
2025
Q4
$7.4K Hold
410
﹤0.01% 3425
2025
Q3
$6.61K Hold
410
﹤0.01% 3450
2025
Q2
$4.46K Sell
410
-678
-62% -$7.59K ﹤0.01% 3680
2025
Q1
$13.6K Buy
1,088
+146
+15% +$2.4K ﹤0.01% 3333
2024
Q4
$18.7K Buy
+942
New +$10.4K ﹤0.01% 3187
2023
Q2
Sell
-627
Closed -$4.13K 4074
2023
Q1
$4.13K Buy
+627
New +$4.15K ﹤0.01% 3583
2022
Q4
Sell
-283
Closed -$1K 4230
2022
Q3
$1K Hold
283
﹤0.01% 3979
2022
Q2
$1K Hold
283
﹤0.01% 3973
2022
Q1
$2K Sell
283
-915
-76% -$7.78K ﹤0.01% 3843
2021
Q4
$12K Buy
1,198
+622
+108% +$7.23K ﹤0.01% 3353
2021
Q3
$7K Hold
576
﹤0.01% 3554
2021
Q2
$8K Sell
576
-236
-29% -$3.7K ﹤0.01% 3488
2021
Q1
$13K Sell
812
-126
-13% -$2.38K ﹤0.01% 3197
2020
Q4
$16K Buy
938
+126
+16% +$3.1K ﹤0.01% 3003
2020
Q3
$30K Hold
812
﹤0.01% 2628
2020
Q2
$19K Buy
812
+151
+23% +$3.23K ﹤0.01% 2843
2020
Q1
$6K Buy
+661
New +$10.1K ﹤0.01% 3193

Other funds holding MESO

US Bancorp's MESO Position: Q2 2026 in Review

US Bancorp held its Mesoblast (MESO) position steady in Q2 2026 at 410 shares worth $5.55K. The position accounts for ﹤0.01% of the portfolio, ranked #3623.

US Bancorp first reported a position in MESO in Q1 2020 and has held it in 19 quarters since. The position peaked at $30K in Q3 2020. 71 funds tracked by Wall St. Rank hold MESO as of Q2 2026.

  • US Bancorp held 410 shares of Mesoblast worth $5.55K as of Q2 2026.
  • US Bancorp left its Mesoblast share count unchanged in Q2 2026.
  • Mesoblast made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #3623 holding.
  • US Bancorp first reported a position in Mesoblast in Q1 2020 and has held it in 19 quarters since.
  • US Bancorp's Mesoblast position peaked at $30K in Q3 2020.
  • 71 funds tracked by Wall St. Rank held Mesoblast as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.